Institut für Technologieentwicklung in der Strahlentherapie – radART
Publikationen

Cone-Beam CT Segmentation for Intraoperative Electron Radiotherapy Based on U-Net Variants with Transformer and Extended LSTM Approaches

Sara Vockner, Matthias Mattke, Ivan M. Messner, Christoph Gaisberger, Franz Zehentmayr, Klarissa Ellmauer, Elvis Ruznic, Josef Karner, Gerd Fastner, Roland Reitsamer, Falk Roeder, Markus Stana , deep learning; Automatic segmentation; Cone beam computed tomography; Intraoperative electron radiotherapy;

Immediate start of durvalumab after chemoradiotherapy in unresectable non-small cell lung cancer UICC stage III: early results from the TORG1937/DATE study

Brane Grambozov, Franz Zehentmayr, Markus Stana

Durvalumab impacts progression-free survival while high-dose radiation > 66 Gy improves local control without excess toxicity in unresectable NSCLC stage III

Franz Zehentmayr, Petra Feurstein, Elvis Ruznic, Brigitte Langer, Brane Grambozov, Marisa Klebermass, Herbert Huepfel, Johann Feichtinger, Danijela Minasch, Martin Heilmann, Barbara Breitfelder, Claudia Steffal, Gisela Gastinger-Grass, Karoline Kirchhammer, Margit Kazil, Heidi Stranzl, Karin Dieckmann, , TOXICITY; Durvalumab; Local control; Non-operable NSCLC; Total radiation dose;

Toxicity and cosmetic outcome after Intraoperative Radiotherapy with Electrons (IOERT) to the partial breast during breast conserving surgery of breast cancer patients in early stages

G. Fastner, R. Reitsamer, C. Gaisberger, M. Stana, C. Fussl, M. Mattke, B. Grambozov, F. Zehentmayr, A. Sir, N. Annon-Eberharter, F. Roeder

Patterns of Temporal Lobe Reaction and Radiation Necrosis after Particle Radiotherapy in Patients with Skull Base Chordoma and Chondrosarcoma-A Single-Center Experience

Matthias Mattke, Matteo Ohlinger, Nina Bougatf, Robert Wolf, Thomas Welzel, Falk Röder, Sabine Gerum, Christoph Fussl , Natalee Annon-Eberharter, Malte Ellerbrock, Oliver Jäkel, Thomas Haberer, Klaus Herfarth, Matthias Uhl, Jürgen Debus, Katharina Seidensaal, Semi Harrabi

First clinical application of image-guided intraoperative electron radiation therapy with real time intraoperative dose calculation in recurrent rectal cancer

Falk Roeder, Gerd Fastner, Christoph Fussl, Felix Sedlmayer, Markus Stana, Johannes Berchtold, Tarkan Jäger, Jaroslav Presl, Philipp Schredl, Klaus Emmanuel, Daniela Colleselli, Gabriel Kotolacsi, Philipp Scherer, Philipp Steininger, Christoph Gaisberger , Humans; ELECTRONS; Radiotherapy, Image-Guided/methods; Rectal Neoplasms/diagnostic imaging; Combined Modality Therapy; Cone-Beam Computed Tomography; Intraoperative Period; Intraoperative Care;

Noninvasive inter- and intrafractional motion control in ultrahypofractionated radiation therapy of prostate cancer using RayPilot HypoCath™-a substitute for gold fiducial-based IGRT?

J. Berchtold, C. Winkler, J. Karner, M. Groher, C. Gaisberger, F. Sedlmayer, F. Wolf , SYSTEM; LOCALIZATION; RADIOTHERAPY; Noninvasive tracking; Prostate motion management; Image-guidance alternatives; Radiosurgery; Margins;

Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DLCO Correlate with Radiation Dosimetry and Pneumonitis Rate

Markus Stana, Brane Grambozov, Josef Karner, Isabella Gollner, Christoph Gaisberger, Elvis Ruznic, Barbara Zellinger, Raphaela Moosbrugger, Michael Studnicka, Gerd Fastner, Felix Sedlmayer, Franz Zehentmayr , VOLUME; MORTALITY; SURVIVAL; PHASE-III; CELL LUNG-CANCER; CISPLATIN; CONFORMAL RADIOTHERAPY; CONCURRENT; SEQUENTIAL CHEMORADIOTHERAPY; CAPACITY PREDICTS;

Pretreatment 18-FDG-PET/CT parameters can serve as prognostic imaging biomarkers in recurrent NSCLC patients treated with reirradiation-chemoimmunotherapy.

Brane Grambozov, Forough Kalantari, Mohsen Beheshti, Markus Stana, Josef Karner, Elvis Ruznic, Barbara Zellinger, Felix Sedlmayer, Gabriel Rinnerthaler, Franz Zehentmayr , SURVIVAL; LOCAL-CONTROL; RADIOTHERAPY; POSITRON-EMISSION-TOMOGRAPHY; METABOLIC TUMOR VOLUME; CELL LUNG-CANCER; DEFINITIVE CHEMORADIATION THERAPY; STANDARDIZED UPTAKE VALUE; F-18-FDG PET; STAGE;

Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3

E. Ruznic, B. Zellinger, U. Bodenhofer, IA Engländer, C. Kronberger, B. Grambozov, M. Stana, J. Karner, G. Fastner, K. Sotlar, F. Sedlmayer, F. Zehentmayr

Investigating focal spot position drift in a mobile imaging system equipped with a monobloc-based x-ray generator

IM Messner, P. Keuschnigg, B. Stoellinger, M. Kraihamer, J. Coste-Marin, P. Huber, D. Kellner, EM Kreuzeder, P. Steininger, H. Deutschmann , CT; focal spot drift; focal spot shift; high resolution imaging; ImagingRing mobile; IRm; Loop-X; misalignment artifact; off-focal radiation; thermal focal spot drift; BEAM; CALIBRATION;

Practice of Radiation Therapy for SCC esophageal cancer in Austria - A Survey of the OGRO-GIT-Group

S. Gerum, W. Iglseder, P. Clemens, P. Harl, R. Jaeger, T. Knocke-Abulesz, G. Kurzweil, K. Peterka, I. Reiter, J. Salinger, R. Schmid, S. Schwaiger, H. Stranzl-Lawatsch, C. Venhoda, F. Sedlmayer, F. Roeder

Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III

Markus Stana, Brane Grambozov, Christoph Gaisberger, Josef Karner, Elvis Ruznic, Johannes Berchtold, Barbara Zellinger, Raphaela Moosbrugger, Michael Studnicka, Gerd Fastner, Felix Sedlmayer, Franz Zehentmayr , THERAPY; VALIDATION; IMPACT; RADIOTHERAPY; COMBINED PULMONARY-FIBROSIS; DENSITY CHANGES; EMPHYSEMA; PNEUMONITIS;

Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3.

Barbara Zellinger, Ulrich Bodenhofer, Immanuela A Engländer, Cornelia Kronberger, Brane Grambozov, Elvis Ruznic, Markus Stana, Josef Karner, Gerd Fastner, Karl Sotlar, Felix Sedlmayer, Franz Zehentmayr , THERAPY; CANCER; GENE; EXPRESSION; DIAGNOSIS; Biomarkers; SUSCEPTIBILITY; GENOME-WIDE ASSOCIATION; DIABETIC-NEPHROPATHY; MICRORNA-3651 PROMOTES;

Irradiation of the locoregional Lymphatic Drainage Pathways of Breast Cancer: Is the prescribed Dose actually applied? A Planning Study by the DEGRO Breast Cancer Working Group

MN Duma, M. Piroth, Gerd Fastner, R. Baumann, S. Combs, J. Dunst, P. Feyer, R. Fietkau, W. Haase, W. Harms, T. Hehr, D. Krug, R. Sauer, Felix Sedlmayer, R. Souchon, V. Strnad, W. Budach

Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity.

Romana Wass, Maximilian Hochmair, Bernhard Kaiser, Brane Grambozov, Petra Feurstein, Gertraud Weiß, Raphaela Moosbrugger, Felix Sedlmayer, Bernd Lamprecht, Michael Studnicka, Franz Zehentmayr , SURVIVAL; RADIOTHERAPY; CONSOLIDATION; CHEMORADIATION; PHASE-III; CELL LUNG-CANCER; CONCURRENT; INHIBITOR-RELATED PNEUMONITIS; REAL-WORLD DATA; RTOG 0617;

Impact of concomitant replacement of the ascending aorta in patients undergoing aortic valve replacement on operative morbidity and mortality

Andreas Winkler, P. Puiu, Philipp Krombholz-Reindl, A. Votsch, Johannes Steindl, Markus Neuner, M. Kirnbauer, Rainald Seitelberger, Roman Gottardi

High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC.

Brane Grambozov, Markus Stana, Bernhard Kaiser, Josef Karner, Sabine Gerum, Elvis Ruznic, Barbara Zellinger, Raphaela Moosbrugger, Michael Studnicka, Gerd Fastner, Felix Sedlmayer, Franz Zehentmayr , SURVIVAL; TOXICITY; CLINICAL-OUTCOMES; PREDICTORS; RADIATION-THERAPY; STEREOTACTIC BODY RADIOTHERAPY; CELL LUNG-CANCER; PROTON-BEAM THERAPY; STAGE-III NSCLC; RADICAL RADIOTHERAPY;

Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases.

Arndt-Christian Müller, Daniel M Aebersold, Clemens Albrecht, Dirk Böhmer, Michael Flentje, Ute Ganswindt, Pirus Ghadjar, Nina-Sophie Schmidt-Hegemann, Stefan Höcht, Tobias Hölscher, Peter Niehoff, Michael Pinkawa, Felix Sedlmayer, Frank Wolf, Constantinos Zamboglou, Daniel Zips, Thomas Wiegel , RADIATION-THERAPY; FRACTIONATION;

[Impact of physical activity before, during, and after chemotherapy on cognitive functions in patients with breast cancer: results of a prospective US study].

Gerd Fastner, Franz Zehentmayr , THERAPY; CANTAB;